avatar
Fatih Yulak Res. Assist. Dr. CUMHURİYET ÜNİVERSİTESİ
Publication 6 Review 1 CrossRef Cited 7
6 Publication
1 Review
7 CrossRef Cited

Research Fields

Cellular Nervous System Medical Physiology Neurology and Neuromuscular Diseases Cell Physiology

Institution

CUMHURİYET ÜNİVERSİTESİ

Popular Publications

The Anticancer Effect of Cannabinoid 2 Agonist L-759,633 on C6 and SH-SY5Y Cell Lines
Authors: Zıad Joha , Fatih Yulak , Ayşegül Öztürk , Bilal Şahin , Şahin Yıldırım
Published: 2021 , Turkish Journal of Science and Health
DOI: 10.51972/tfsd.929180
CITED 3 FAVORITE 1 TOTAL DOWNLOAD COUNT 784

3

1

784

Publications

Investigation of the Effect of Indatraline on Oxidative Damage Induced by Hydrogen Peroxide in C6 Glioma Cell Line
Authors: Fatih Yulak , Bünyamin Üngür
Published: 2023 , Cumhuriyet Science Journal
DOI: 10.17776/csj.1340869
FAVORITE 0 TOTAL DOWNLOAD COUNT 629

0

629

Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line
Authors: Zekeriya Keskin , Fatih Yulak , Hatice Terzi , Merve İnanır
Published: 2023 , Cumhuriyet Science Journal
DOI: 10.17776/csj.1344535
FAVORITE 0 TOTAL DOWNLOAD COUNT 652

0

652

Investigation of The Antiproliferative Effect of Colchicine on SNU-1 Gastric Cancer Cells
Authors: Fatih Yulak
Published: 2023 , Cumhuriyet Science Journal
DOI: 10.17776/csj.1256954
FAVORITE 0 TOTAL DOWNLOAD COUNT 1024

0

1024

Levetiracetam Protects Against Glutamate-Induced Excitotoxicity in SH-SY5Y Cell Line
Authors: Arzuhan Çetindağ Çiltaş , Sema Gündoğdu , Fatih Yulak
Published: 2022 , International Journal of Nature and Life Sciences
DOI: 10.47947/ijnls.1187054
FAVORITE 0 TOTAL DOWNLOAD COUNT 1258

0

1258

Investigation of the potential antitumor activity of PLK1 inhibitor SBE13 in colon cancer cell line HT29
Authors: Muhammed Gömeç , Fatih Yulak , Mustafa Ergül
Published: 2022 , Cumhuriyet Medical Journal
DOI: 10.7197/cmj.1107200
FAVORITE 0 TOTAL DOWNLOAD COUNT 1040

0

1040

The Anticancer Effect of Cannabinoid 2 Agonist L-759,633 on C6 and SH-SY5Y Cell Lines
Authors: Zıad Joha , Fatih Yulak , Ayşegül Öztürk , Bilal Şahin , Şahin Yıldırım
Published: 2021 , Turkish Journal of Science and Health
DOI: 10.51972/tfsd.929180
FAVORITE 1 TOTAL DOWNLOAD COUNT 784

1

784

Articles published in
Cumhuriyet Medical Journal
Cumhuriyet Medical Journal
Cumhuriyet Science Journal
Cumhuriyet Science Journal
International Journal of Nature and Life Sciences
International Journal of Nature and Life Sciences
Turkish Journal of Science and Health
Turkish Journal of Science and Health

Reviews

Duzce Medical Journal
Duzce Medical Journal

Publications

Investigation of the Effect of Indatraline on Oxidative Damage Induced by Hydrogen Peroxide in C6 Glioma Cell Line
Authors: Fatih Yulak , Bünyamin Üngür
Published: 2023 , Cumhuriyet Science Journal
DOI: 10.17776/csj.1340869
CITED 1 FAVORITE 0 TOTAL DOWNLOAD COUNT 629

1

0

629

Levetiracetam Protects Against Glutamate-Induced Excitotoxicity in SH-SY5Y Cell Line
Authors: Arzuhan Çetindağ Çiltaş , Sema Gündoğdu , Fatih Yulak
Published: 2022 , International Journal of Nature and Life Sciences
DOI: 10.47947/ijnls.1187054
CITED 3 FAVORITE 0 TOTAL DOWNLOAD COUNT 1258

3

0

1258

The Anticancer Effect of Cannabinoid 2 Agonist L-759,633 on C6 and SH-SY5Y Cell Lines
Authors: Zıad Joha , Fatih Yulak , Ayşegül Öztürk , Bilal Şahin , Şahin Yıldırım
Published: 2021 , Turkish Journal of Science and Health
DOI: 10.51972/tfsd.929180
CITED 3 FAVORITE 1 TOTAL DOWNLOAD COUNT 784

3

1

784

Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods. : Click to get information about the DergiPark User Badge.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.